|
ACHL
|
Achilles Therapeutics plc
|
US
|
NASDAQ
|
|
ASND
|
Ascendis Pharma A/S
|
US
|
NASDAQ
|
|
CMPS
|
COMPASS Pathways Plc
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
HUMA
|
Humacyte, Inc.
|
US
|
NASDAQ
|
|
PPBT
|
Purple Biotech Ltd.
|
US
|
NASDAQ
|
|
PROK
|
ProKidney Corp.
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
|
PRRUF
|
Immutep Ltd
|
US
|
OTC
|
|
ONC
|
Oncolytics Biotech Inc.
|
CA
|
TSX
|
|
GMAB
|
Genmab A/S
|
DK
|
CO
|
|
4AB
|
AbbVie Inc
|
DE
|
F
|
|
FYB
|
Formycon AG
|
DE
|
F
|
|
O2T
|
IVERIC bio Inc
|
DE
|
F
|
|
2197
|
Clover Biopharmaceuticals Ltd
|
HK
|
HK
|
|
9995
|
Remegen Co Ltd
|
HK
|
HK
|